Buleje Jose, Guevara-Fujita Maria, Acosta Oscar, Huaman Francia D P, Danos Pierina, Murillo Alexis, Pinto Joseph A, Araujo Jhajaira M, Aguilar Alfredo, Ponce Jaime, Vigil Carlos, Castaneda Carlos, Calderon Gabriela, Gomez Henry L, Fujita Ricardo
Centro de Genética y Biología MolecularFacultad de Medicina HumanaUniversidad de San Martín de PorresLimaPerú.
Unidad de Investigación Básica y TraslacionalOncosalud-AUNALimaPerú.
Mol Genet Genomic Med. 2017 Jun 28;5(5):481-494. doi: 10.1002/mgg3.301. eCollection 2017 Sep.
Breast cancer is one of the most prevalent malignancies in the world. In Peru, breast cancer is the second cause of death among women. Five to ten percent of patients present a high genetic predisposition due to and germline mutations.
We performed a comprehensive analysis of and genes by Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA) to detect large rearrangements in patients from 18 families, which met the criteria for hereditary breast cancer.
In this series, we found four pathogenic mutations, three previously reported (: c.302-1G>C and c.815_824dup10; : c.5946delT) and a duplication of adenines in exon 15 in gene (c.4647_4648dupAA, ClinVar SCV000256598.1). We also found two exonic and four intronic variants of unknown significance and 28 polymorphic variants.
This is the first report to determine the spectrum of mutations in the genes in Peruvian families selected by clinical and genetic criteria. The alteration rate in with proven pathogenic mutation was 22.2% (4 out 18) and this finding could be influenced by the reduced sample size or clinical criteria. In addition, we found three known mutations and a c.4647_4648dupAA as a novel pathogenic mutation.
乳腺癌是全球最常见的恶性肿瘤之一。在秘鲁,乳腺癌是女性第二大死因。5%至10%的患者由于 和 种系突变而具有高度遗传易感性。
我们通过桑格测序和多重连接依赖探针扩增(MLPA)对 和 基因进行了全面分析,以检测来自18个符合遗传性乳腺癌标准家庭的患者中的大片段重排。
在本系列研究中,我们发现了四个致病突变,三个先前已报道( :c.302-1G>C和c.815_824dup10; :c.5946delT)以及 基因外显子15中腺嘌呤的重复(c.4647_4648dupAA,ClinVar SCV000256598.1)。我们还发现了两个意义不明的外显子变体和四个内含子变体以及28个多态性变体。
这是第一份确定根据临床和遗传标准选择的秘鲁家庭中 基因突变异质性的报告。经证实有致病突变的 基因改变率为22.2%(18例中有4例),这一发现可能受样本量减少或临床标准的影响。此外,我们发现了三个已知的 突变和一个 c.4647_4648dupAA作为新的致病突变。